CAPS

Capstone Holding Corp. Common Stock
Consumer Defensive — WHOLESALE-LUMBER & OTHER CONSTRUCTION MATERIALS
Valhalla Score 43
A proprietary composite score from 0–100 measuring a stock's technical strength, sector-relative performance, and institutional flow activity. Higher scores indicate stronger setups.
$0.42

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

📊 Key Statistics

Market Cap$5M
P/E Ratio
EPS (TTM)
EPS YoY
Revenue YoY
Float
Short Float %
Inst. Ownership
Sector RS

📈 Fundamentals

ROE
ROIC
ROA
Current Ratio
Debt/Equity
Gross Margin
Net Margin
Dividend Yield
Next Earnings

Options Summary

Call OI
Put OI
P/C Ratio (OI)
Gamma Environment
Max Pain
Call Wall
Put Wall

🎯 Analyst Estimates

Consensus Target
High Target
Low Target
Analysts
Upside/Downside

📋 Quarterly Financials

Period Revenue Rev YoY EPS EPS YoY Gross Margin
Start Free Trial See full options flow, dark pool data & more

🔥 Recent Options Flow

TypeStrikeExpSizePremiumTime
Start Free Trial Institutional trades, dark pool vs lit exchange

🏛️ Institutional Trades

TypePriceSizeValueVenueTime
Start Free Trial Full insider & congressional trade history

👤 Insider Trades

NameTypeSharesPriceDate
Start Free Trial Top institutional holders & ownership data

🏦 Top Institutional Holders

InstitutionSharesValue% of Class

Start Your Free Trial

Have a referral code?

14-day free trial then $70/month. Cancel anytime.

Welcome to Valhalla